‘Game-changing’ partnership announced for emerging exosome field
Sartorius BIA Separations and Exopharm are teaming up on research to develop integrated technology for large-scale exosome production.
Archives for November 24, 2022
Glenzocimab to enter Phase 2 trial for heart attack patients
A Phase 2b study will test the tolerance and efficacy of glenzocimab to reduce heart damage following myocardial infarction.
FDA approves first gene therapy for hemophilia B
CSL’s Hemgenix (etranacogene dezaparvovec-drlb) becomes the first treatment to offer patients freedom from regular ongoing infusions.